Format

Send to

Choose Destination
Clin Chest Med. 2004 Mar;25(1):133-40.

Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis.

Author information

1
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, C272, Denver, CO 80262, USA. marvin.schwarz@uchsc.edu

Abstract

Current and past drug intake is essential in the evaluation of a patient who has DAH. Simple treatments, such as reversal of a coagulation defect or withdrawal of the drug, can reverse a life-threatening situation. DAO may result in DAH, and depending on the severity of the drug withdrawl, will not be adequate and corticosteroid therapy is recommended.

PMID:
15062605
DOI:
10.1016/S0272-5231(03)00139-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center